1401, 18e Rue
P-0143
Québec, Québec
Canada G1J 1Z4

Dernières nouvelles

Information non disponible

17 enregistrements « 1 de 2 »

Kushol R, Luk CC, Dey A, Benatar M, Briemberg H, Dionne A, Dupré N, Frayne R, Genge A, Gibson S, Graham SJ, Korngut L, Seres P, Welsh RC, Wilman AH, Zinman L, Kalra S, Yang YH

SF2Former: Amyotrophic lateral sclerosis identification from multi-center MRI data using spatial and frequency fusion transformer

Article de revue

Comput Med Imaging Graph, 108 , 2023.

Résumé | Liens:

Bouvier L, McKinlay S, Truong J, Genge A, Dupré N, Dionne A, Kalra S, Yunusova Y

Speech timing and monosyllabic diadochokinesis measures in the assessment of amyotrophic lateral sclerosis in Canadian French

Article de revue

Int J Speech Lang Pathol, 2023.

Résumé | Liens:

GomezMancilla B, Meriggioli MN, Genge A, Roubenoff R, Espié P, Dupuy C, Hartmann N, Pezous N, Kinhikar A, Tichy M, Dionne A, Vissing J, Andersen H, Schoser B, Meisel A, Jordan B, Devlikamova F, Poverennova I, Stuchevskaya F, Lin TS, Rush JS, Gergely P

Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized study

Article de revue

J Clin Neurosci, 119 , 2023.

Résumé | Liens:

Picher-Martel V, Magnussen C, Blais M, Bubela T, Das S, Dionne A, Evans AC, Genge A, Greiner R, Iturria-Medina Y, Johnston W, Jones K, Kaneb H, Karamchandani J, Moradipoor S, Robertson J, Rogaeva E, Taylor DM, Vande Velde C, Yunusova Y, Zinman L, Kalra S, Dupré N

CAPTURE ALS: the comprehensive analysis platform to understand, remedy and eliminate ALS

Article de revue

Amyotroph Lateral Scler Frontotemporal Degener, 24 (1-2), 2023.

Résumé | Liens:

Salmon K, Anoja N, Breiner A, Chum M, Dionne A, Dupré N, Fiander A, Fok D, Ghavanini A, Gosselin S, Izenberg A, Johnston W, Kalra S, Matte G, Melanson M, O'Connell C, Ritsma B, Schellenberg K, Shoesmith C, Tremblay S, Williams H, Genge A

Genetic testing for amyotrophic lateral sclerosis in Canada - an assessment of current practices

Article de revue

Amyotroph Lateral Scler Frontotemporal Degener, 23 (3-4), 2022.

Résumé | Liens:

Ishaque A, Ta D, Khan M, Zinman L, Korngut L, Genge A, Dionne A, Briemberg H, Luk C, Yang YH, Beaulieu C, Emery D, Eurich DT, Frayne R, Graham S, Wilman A, Dupré N, Kalra S

Distinct patterns of progressive gray and white matter degeneration in amyotrophic lateral sclerosis

Article de revue

Hum Brain Mapp, 43 (5), 2022.

Résumé | Liens:

McMillan CT, Wuu J, Rascovsky K, Cosentino S, Grossman M, Elman L, Quinn C, Rosario L, Stark JH, Granit V, Briemberg H, Chenji S, Dionne A, Genge A, Johnston W, Korngut L, Shoesmith C, Zinman L, , Kalra S, Benatar M

Defining cognitive impairment in amyotrophic lateral sclerosis: an evaluation of empirical approaches

Article de revue

Amyotroph Lateral Scler Frontotemporal Degener, 23 (7-8), 2022.

Résumé | Liens:

Bharti K, J Graham S, Benatar M, Briemberg H, Chenji S, Dupré N, Dionne A, Frayne R, Genge A, Korngut L, Luk C, Zinman L, Kalra S,

Functional alterations in large-scale resting-state networks of amyotrophic lateral sclerosis: A multi-site study across Canada and the United States

Article de revue

PLoS One, 17 (6), 2022.

Résumé | Liens:

Eshghi M, Yunusova Y, Connaghan KP, Perry BJ, Maffei MF, Berry JD, Zinman L, Kalra S, Korngut L, Genge A, Dionne A, Green JR

Rate of speech decline in individuals with amyotrophic lateral sclerosis

Article de revue

Sci Rep, 12 (1), 2022.

Résumé | Liens:

Shefner JM, Andrews JA, Genge A, Jackson C, Lechtzin N, Miller TM, Cockroft BM, Meng L, Wei J, Wolff AA, Malik FI, Bodkin C, Brooks BR, Caress J, Dionne A, Fee D, Goutman SA, Goyal NA, Hardiman O, Hayat G, Heiman-Patterson T, Heitzman D, Henderson RD, Johnston W, Karam C, Kiernan MC, Kolb SJ, Korngut L, Ladha S, Matte G, Mora JS, Needham M, Oskarsson B, Pattee GL, Pioro EP, Pulley M, Quan D, Rezania K, Schellenberg KL, Schultz D, Shoesmith C, Simmons Z, Statland J, Sultan S, Swenson A, Berg LHVD, Vu T, Vucic S, Weiss M, Whyte-Rayson A, Wymer J, Zinman L, Rudnicki SA

A Phase 2, Double-Blind, Randomized, Dose-Ranging Trial Of Reldesemtiv In Patients With ALS

Article de revue

Amyotroph Lateral Scler Frontotemporal Degener, 22 (3-4), 2021.

Résumé | Liens:

17 enregistrements « 1 de 2 »
Signaler des ajouts ou des modifications

Projets actifs

  • Élaboration d'une base de données pour la clinique des maladies neuromusculaires du CHU de Québec , du 2022-04-01 au 2026-03-31
Information provenant du registre des projets de recherche de l'Université Laval